Essential role of sulfide oxidation in brain health and neurological disorders
- 22 December 2024
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 266, 108787
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R21 NS116671)
- Kyowa Kirin Co Ltd
- National Institute of Neurological Disorders and Stroke (R01 NS112373)
This publication has 172 references indexed in Scilit:
- Global estimates on the number of persons across the Alzheimer's disease continuumAlzheimer's & Dementia, 2022
- A defect in molybdenum cofactor binding causes an attenuated form of sulfite oxidase deficiencyJournal of Inherited Metabolic Disease, 2021
- Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementiasAlzheimer's & Dementia, 2021
- Hydrogen Sulfide Oxidation by Sulfide Quinone OxidoreductaseChemBioChem, 2020
- Pathogenic variants in SQOR encoding sulfide:quinone oxidoreductase are a potentially treatable cause of Leigh diseaseJournal of Inherited Metabolic Disease, 2020
- Data‐Driven Identification of Hydrogen Sulfide ScavengersAngewandte Chemie International Edition, 2019
- Leigh syndrome: One disorder, more than 75 monogenic causesAnnals of Neurology, 2015
- Effective AAV‐mediated gene therapy in a mouse model of ethylmalonic encephalopathyEMBO Molecular Medicine, 2012
- The interaction of human neuroglobin with hydrogen sulphideIUBMB Life, 2008
- Leigh syndrome: Clinical features and biochemical and DNA abnormalitiesAnnals of Neurology, 1996